SCHEMBL26833518

SCHEMBL26833518

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7ccc8nnccc8c7)cc6)c6ccc(-c7ccc8nnccc8c7)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.43
▸ NPC1 O15118 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ CYP17A1 P05093 1/20 0.37
▸ CYP19A1 P11511 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ BACE1 P56817 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ NISCH Q9Y2I1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833495 0.95 SRC (0.41) SRCNPC1POLBRAB9AESR1
SCHEMBL26833562 0.86 SRC (0.35) SRCNPC1POLBRAB9AESR1
SCHEMBL26834584 0.85 NPC1 (0.57) SRCNPC1POLBRAB9AESR1
SCHEMBL26833501 0.84 NPC1 (0.44) SRCNPC1POLBRAB9AESR1
SCHEMBL26833570 0.84 SIRT2 (0.34) SRCESR1ESR2CYP17A1CYP19A1
SCHEMBL24687203 0.83 ESR1 (0.46) SRCESR1ESR2CYP17A1CYP19A1
SCHEMBL20466431 0.83 ESR1 (0.46) SRCESR1ESR2CYP17A1CYP19A1
SCHEMBL20466434 0.83 ESR1 (0.46) SRCESR1ESR2CYP17A1CYP19A1
SCHEMBL26833455 0.83 PRKCZ (0.50) NPC1RAB9AESR1ESR2PIK3CD
SCHEMBL26833454 0.83 CYP17A1 (0.48) NPC1RAB9AESR1ESR2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 SRC 2187/4885NPC1 2396/4885POLB 2432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback